Tobacco smoke contains a number of genotoxic compounds that are metabolized to their biologically active forms that subsequently react with cellular DNA to form covalently boundcarcinogen-DNA adducts. Several analytical procedures have been developed to detect these adducts in human tissues. Using the nuclease P1-enhanced 32P-postlabeling procedure for bulky adducts, we have detected at least 24 adducts in DNA isolated from placenta and umbilical cord DNA. Adducts were detected in both smokers and nonsmokers, but the relative adduct level (RAL) was significantly higher in smokers (42. 8, 8 cases) than in nonsmokers (19.7, 11 cases). The origin of the adducts in nonsmokers remains unknown. The adduct levels in artery DNA were significantly lower than in the vein and the placenta, and a paired nonparametric analysis showed a significant association between the adduct levels in the three tissues. Our results show a maternal transfer of carcinogens present in cigarette smoke to fetal tissues and show that the tissues can metabolize the carcinogens to their DNA binding metabolites. The presence of adducts in fetal tissues may be indicative of genomic damage and may predispose the individual for the development of a serious disease iter in life.
Introduction
Epidemiological and laboratory investigations have shown that environmental carcinogens, including the ones found in tobacco smoke, play an important role in the etiology ofcancer [e.g., cancer of the lung, larynx, oral cavity, and bladder (1) ]. Recently, it has been proposed that chemical carcinogens may also be involved in the development of various forms of cardiovascular disease (2, 3) . In addition, smoking tobacco products during pregnancy is associated with an increased risk to the unborn child, resulting in preterm delivery, decreased birth weight, stillbirth, and a number of serious congenital malformations (4) (5) (6) .
Chemical carcinogens are metabolized in a number ofhuman tissues and cells (7, 8) , and smoking related carcinogen-DNA adducts have been detected in human tissue (9) (10) (11) . The adduct levels in lung tissue correlate with the number of cigarettes smoked, and these adducts are retained for a relatively long period after cessation of smoking (9) in the lungs and livers of aborted fetuses (5, 12, 13) .
We report that covalently bound DNA adducts, as assessed by 32P-postlabeling, are present in the placenta as well as in umbilical cord vasculature obtained from otherwise healthy smoking and nonsmoking donors. Adduct levels were found to be significantly higher in smokers as compared to nonsmokers. Maternal adduct levels were significantly higher than fetal levels, and marginally significant differences were obtained between adduct levels in the three tissues when smokers and nonsmokers were compared.
Materials and Methods
Donors. Nineteen completely healthy women were selected, all of whom had had an uncomplicated pregnancy and delivery and who had given birth to healthy, full-term children without any abnormalities and with an Apgar score of 10/10. Prior to the collection, all the women gave informed consent according to the Helsinki II declaration. According to the questionnaire, 11 of these women were nonsmokers, including 3 who had ceased smoking more than a year before pregnancy. The smoking group comprised eight women, of whom two said that they smoked less than 10 cigarettes daily.
Isolation of Tissues and DNA. Tissue blocks were obtained from placenta and umbilical cord within 4 
Relative Adduct Levels
Large interindividual variation was observed in total adduct levels (RAL value) in tissues from both smokers and nonsmokers. Smokers had higher adduct levels as compared to nonsmokers. RAL values in smokers regardless oftissue, compared with nonsmokers (Table 1) were significantly different (p = 0.021) using an unpaired Student's t-test, and the adduct level in maternal tissue was significandy higher (p = 0.030) than in fetal tissue. No statistical difference was observed when total fetal adduct levels between smokers and nonsmokers were compared (p = 0.089).
The mean value of RAL in placenta from smokers and nonsmokers was equivalent to that in the corresponding um- (5, 12, 18) . Using the 32P-postlabeling technique, carcinogen-DNA adducts have been detected in umbilical cord vein and artery in addition to placenta from both nonsmoking and smoking women. The adducts in nonsmokers must be ascribed to chemical compounds present in the general environment. The tissue donors lived in a highly populated area of Copenhagen. An alternative explanation for these background spots in nonsmoking donors could be that these adducts originate from intrinsic factors (19) or are related to age or dietary products (20) . Third, the presence of background adduct spots in nonsmokers may be indicative ofpassive smoking, but information on exposure to environmental tobacco smoke was not obtained. The observation that covalently bound DNA adducts were present not only in the placenta but also in umbilical cord vein and artery, two tissues of solely fetal origin, indicates that the fetus is transplacentally exposed to genotoxic compounds found in the general environment. We have not been able to show any correlation between distinct adduct spots and maternal smoking, similar to other investigators.
Mean adduct levels in tissues from smokers were significantly higher than in tissues from nonsmokers. Large interindividual variation in the relative adduct level was observed within both the smoker and nonsmoker group. For smokers, the number of cigarettes smoked per day may have an effect as seen in human lung (10) . More than a 70-fold variation in the level of aryl hydrocarbon hydroxylase activity was observed in placental tissues. This combined with differences in DNA repair capabilities could influence adduct levels (9) .
The mean adduct level in maternal tissues was significantly higher than the level in fetal tissue. To reach fetal tissues, compounds must diffuse across the placental barrier, which may retain several compounds due to differences in hydrophobicity. 
